The TP508 Solution for Nuclear Radiation Exposure

Increasing Threat of a Nuclear Accident or Intentional Detonation 

  • Potential that hundreds of thousands of people exposed to high levels of nuclear radiation will suffer from acute radiation syndromes (ARS) or delayed organ failure 
  • Risk to military and first-responders who must enter highly radioactive areas
  • Need for easily administered and highly effective medicinal countermeasures 
  • TP508 mitigates radiation damage to significantly increase survival

Preclinical studies demonstrate that TP508 injection 24 hours after lethal doses of nuclear radiation significantly increases survival. Extensive research indicates that TP508 treatment following a nuclear incident could prevent mortality in individuals exposed to high levels of radiation and reduce delayed effects of radiation to increase quality of life for survivors.